buserelin has been researched along with cyproterone acetate in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (50.00) | 18.7374 |
| 1990's | 18 (47.37) | 18.2507 |
| 2000's | 1 (2.63) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baccari, GC; Di Matteo, L; Fasano, S; Minucci, S; Pierantoni, R | 1 |
| Schmeller, N | 1 |
| Yokoya, S | 1 |
| Huhtaniemi, I; Parvinen, M; Rannikko, S; Venho, P | 1 |
| Schulze, H; Senge, T | 1 |
| D'Eramo, G; Di Silverio, F; Sciarra, F | 1 |
| De Pauw, M; de Voogt, HJ; Klijn, JG; Schröder, F; Studer, U; Sylvester, R | 1 |
| Moffat, LE | 1 |
| D'Eramo, G; Di Silverio, F; Sciarra, F; Serio, M | 1 |
| Blom, JH; Bosch, RJ; Griffiths, DJ; Schroeder, FH | 1 |
| Hartmann, A; Mann, K | 1 |
| Waxman, J | 1 |
| Cordeschi, G; Francavilla, S; Galassi, P; Miano, L; Paradiso Galatioto, G; Properzi, G; Vicentini, C | 1 |
| de Jong, FH; Lamberts, SW; Uitterlinden, P | 1 |
| Abel, P; Cox, J; Farah, N; Fleming, J; Hewitt, G; O'Donoghue, EP; Sandow, J; Sikora, K; Waxman, J; Williams, G | 1 |
| Bolton, C; Gingell, JC; Hartog, M; Kadow, C; Paisey, RB | 1 |
| Drop, SL; Ladée-Levy, JV; Pouw, IS; Slijper, FM | 1 |
| Boccon-Gibod, L; Dugue, MA; Laudat, MH; Steg, A | 1 |
| Chadha, DR; de Jong, FH; de Voogt, HJ; Debruyne, FM; Karthaus, HF; Klijn, JG; Lock, TM; Matroos, AW; Schroeder, FH | 1 |
| Claes, HI; Vandenbussche, L; Vereecken, RL | 1 |
| al-Abadi, H; Borgmann, V; Nagel, R | 1 |
| Debruyne, FM | 1 |
| Hjertberg, H; Kågedal, B; Nordenskjöld, B; Svensson, M; Varenhorst, E | 1 |
| Baldini, A; Carani, C; Pacchioni, C; Zini, D | 1 |
| Bouffioux, C | 1 |
| Alioth, H; Müller, J; Senn, E | 1 |
| Engelbart, K; Sandow, J; von Rechenberg, W | 1 |
| Allen, JM; Bloom, SR; Kerle, D; O'Shea, JP; Smith, C; Williams, G; Yeo, T | 1 |
| Juul, A; Krabbe, S; Müller, J; Nielsen, CT; Scheike, T; Skakkebaek, NE | 1 |
| Gerhard, I; Matthes, J; Runnebaum, B | 1 |
| De Pauw, M; de Voogt, HJ; Klijn, JG; Schröder, FH; Studer, UE; Sylvester, R | 1 |
| Flyvbjerg, A; Frystyk, J; Juul, A; Müller, J; Skakkebaek, NE | 1 |
| Juul, A; Müller, J; Skakkebaek, NE | 1 |
| Baroncelli, GI; Bertelloni, S; Cappa, M; De Sanctis, C; Lala, R; Matarazzo, P; Saggese, G | 1 |
| de Voogt, H; Denis, L; Sylvester, RJ | 1 |
| de Pauw, M; de Voogt, HJ; Klijn, JG; Schröder, FH; Studer, U; Sylvester, R | 1 |
| Anzo, M; Hasegawa, T; Ishii, T; Matsuo, N; Sasaki, G; Sato, S; Tamai, S | 1 |
| Andersson, AM; Müller, J; Sehested, A; Skakkebaek, NE | 1 |
1 review(s) available for buserelin and cyproterone acetate
| Article | Year |
|---|---|
[LHRH agonists combined with antiandrogens in the treatment of metastasizing prostatic carcinoma].
Topics: Androgen Antagonists; Animals; Buserelin; Cyproterone; Cyproterone Acetate; Dogs; Drug Therapy, Combination; Flutamide; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Rats; Receptors, Cell Surface; Receptors, LHRH | 1985 |
15 trial(s) available for buserelin and cyproterone acetate
| Article | Year |
|---|---|
Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
Topics: Aged; Androgen Antagonists; Anilides; Buserelin; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Random Allocation | 1990 |
Orchidectomy versus Buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-trial 30843.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Cyproterone Acetate; Europe; Humans; Male; Middle Aged; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Risk Factors | 1990 |
Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Topics: Androgen Antagonists; Breast; Buserelin; Cardiovascular Diseases; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Goserelin; Humans; Male; Prospective Studies; Prostatic Neoplasms | 1990 |
Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cyproterone; Cyproterone Acetate; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Prostatic Neoplasms; Testosterone | 1990 |
Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters.
Topics: Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Humans; Male; Prospective Studies; Prostate; Prostatic Hyperplasia; Random Allocation; Ultrasonography; Urodynamics | 1989 |
Short-term anti-androgen therapy and very long-acting depot gonadotrophin-releasing hormone agonist for prostatic cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Buserelin; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Flutamide; Humans; Male; Middle Aged; Prostatic Neoplasms; Random Allocation | 1989 |
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogue.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Flutamide; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; Random Allocation; Testosterone | 1988 |
Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Buserelin; Carcinoma; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Cytophotometry; DNA, Neoplasm; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Staging; Prostate; Prostatic Neoplasms; Remission Induction | 1988 |
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Topics: Aged; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Orchiectomy; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
Total androgen blockade in advanced prostatic cancer. Critical review and personal experience.
Topics: Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Time Factors | 1988 |
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrog
Topics: Adolescent; Age Factors; Androgen Antagonists; Buserelin; Child; Child, Preschool; Cyproterone Acetate; Delayed-Action Preparations; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Hormones; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Luteinizing Hormone; Luteolytic Agents; Puberty; Puberty, Precocious; Triptorelin Pamoate | 1995 |
The induction of ovulation with pulsatile gonadotrophin-releasing hormone (GnRH) administration in hyperandrogenic women after down-regulation with buserelin or suppression with an oral contraceptive.
Topics: Adult; Buserelin; Contraceptives, Oral, Combined; Cyproterone Acetate; Down-Regulation; Drug Combinations; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Infertility, Female; Infusion Pumps; Ovulation Induction | 1993 |
Short-term versus long-term addition of cyproterone acetate to buserelin therapy in comparison with orchidectomy in the treatment of metastatic prostate cancer. European Organization for Research and Treatment of Cancer--Genitourinary Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone Acetate; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms | 1993 |
The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials. European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Tract Cancer Cooperative Group.
Topics: Aged; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone Acetate; Disease-Free Survival; Flutamide; Goserelin; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Survival Rate | 1998 |
Maximum androgen blockade using LHRH agonist buserelin in combination with short-term (two weeks) or long-term (continuous) cyproterone acetate is not superior to standard androgen deprivation in the treatment of advanced prostate cancer. Final analysis o
Topics: Acid Phosphatase; Administration, Intranasal; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Cause of Death; Cyproterone Acetate; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Subcutaneous; Male; Middle Aged; Orchiectomy; Pain Measurement; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Survival Rate; Treatment Outcome | 1998 |
22 other study(ies) available for buserelin and cyproterone acetate
| Article | Year |
|---|---|
Intratesticular control of spermatogenesis in the frog, Rana esculenta.
Topics: Animals; Buserelin; Cyproterone Acetate; Hypophysectomy; Male; Mitotic Index; Rana esculenta; Spermatogenesis; Testis | 1992 |
[A 79-year-old man with metastatic prostate cancer, treated with Zoladex, flutamide, calcitonin and Ostac, suffers from frequent troublesome sweating with palpitation and angina pectoris, especially at night. Is there a therapy?].
Topics: Aged; Androgen Antagonists; Angina Pectoris; Buserelin; Calcitonin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Hyperhidrosis; Male; Prostatic Neoplasms | 1992 |
[Etiology and therapy of virilism and precocious puberty].
Topics: Adrenal Hyperplasia, Congenital; Buserelin; Child; Cyproterone; Cyproterone Acetate; Dexamethasone; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Puberty, Precocious; Virilism | 1992 |
Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effects.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Buserelin; Cyproterone; Cyproterone Acetate; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Radioimmunoassay; Receptors, Gonadotropin; Testis; Testosterone | 1991 |
Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Luteinizing Hormone; Male; Premedication; Prostatic Neoplasms; Testosterone; Time Factors | 1990 |
[Therapy with LHRH analogs in a 41-year-old patient with metastatic breast cancer].
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Femoral Neoplasms; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Male; Tamoxifen; Triptorelin Pamoate | 1989 |
Testicular changes after treatment with a GnRH analog (buserelin) in association with cyproterone acetate in men with prostatic cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Humans; Leydig Cells; Male; Middle Aged; Prostatic Neoplasms; Sertoli Cells; Spermatogenesis; Testicular Diseases; Testosterone | 1989 |
Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Topics: Adrenocorticotropic Hormone; Animals; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Goserelin; Imidazoles; Imidazolidines; Ketoconazole; Luteinizing Hormone; Male; Orchiectomy; Organ Size; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains | 1988 |
Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate.
Topics: Buserelin; Cyproterone; Cyproterone Acetate; Goserelin; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Prostatic Neoplasms; Urologic Diseases | 1986 |
[Pseudo- and central precocious puberty due to adrenogenital syndrome].
Topics: Adrenal Hyperplasia, Congenital; Buserelin; Child; Child, Preschool; Cyproterone; Cyproterone Acetate; Disorders of Sex Development; Female; Genitalia; Humans; Hydrocortisone; Male; Puberty, Precocious | 1986 |
Cyproterone acetate lead-in prevents initial rise of serum testosterone induced by luteinizing hormone-releasing hormone analogs in the treatment of metastatic carcinoma of the prostate.
Topics: Aged; Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Humans; Male; Premedication; Prostatic Neoplasms; Testosterone | 1986 |
Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetate.
Topics: Buserelin; Cyproterone; Cyproterone Acetate; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Prospective Studies; Prostatic Neoplasms; Testosterone; Time Factors | 1987 |
Treatment of advanced carcinoma of the prostate by LHRH-agonists.
Topics: Buserelin; Cyproterone; Cyproterone Acetate; Goserelin; Humans; Male; Prostatic Neoplasms; Testosterone | 1987 |
Treatment of prostatic cancer by monthly injections of an LHRH-analogue depot.
Topics: Aged; Aged, 80 and over; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1988 |
Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea.
Topics: Buserelin; Child, Preschool; Cyproterone; Cyproterone Acetate; Estradiol; Estrogens; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Lactation Disorders; Luteinizing Hormone; Ovary; Prolactin; Puberty, Precocious | 1988 |
The different mechanisms for suppression of pituitary and testicular function.
Topics: Androgen Antagonists; Animals; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Humans; Leydig Cells; Luteinizing Hormone; Male; Pituitary Gland; Progesterone; Rats; Receptors, Cell Surface; Receptors, LHRH; Spermatogenesis; Testosterone | 1986 |
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Topics: Adenocarcinoma; Buserelin; Castration; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1984 |
Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.
Topics: Adolescent; Analysis of Variance; Androgen Antagonists; Buserelin; Child; Cyproterone Acetate; Endopeptidases; Gonadotropin-Releasing Hormone; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Male; Puberty; Puberty, Precocious; Regression Analysis | 1996 |
Prostate specific antigen in boys with precocious puberty before and during gonadal suppression by GnRH agonist treatment.
Topics: Adolescent; Adult; Androgen Antagonists; Biomarkers; Buserelin; Child; Cyproterone Acetate; Female; Gonadotropin-Releasing Hormone; Humans; Male; Prostate-Specific Antigen; Puberty, Precocious; Radioimmunoassay; Sex Hormone-Binding Globulin; Testis; Testosterone | 1997 |
Long-term outcome of male-limited gonadotropin-independent precocious puberty.
Topics: Androgen Antagonists; Buserelin; Child; Child, Preschool; Cyproterone Acetate; Drug Therapy, Combination; Follicle Stimulating Hormone; Humans; Ketoconazole; Luteinizing Hormone; Male; Puberty, Precocious; Receptors, LH; Testosterone | 1997 |
Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.
Topics: Administration, Inhalation; Administration, Oral; Body Height; Buserelin; Child, Preschool; Cyproterone Acetate; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Growth Disorders; Hamartoma; Humans; Hypothalamic Diseases; Magnetic Resonance Imaging; Male; Progesterone Congeners; Puberty, Precocious; Treatment Outcome; Twins, Monozygotic | 1999 |
Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists.
Topics: Buserelin; Child; Child, Preschool; Cyproterone Acetate; Female; Fertility; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Inhibins; Prostatic Secretory Proteins; Puberty, Precocious; Triptorelin Pamoate | 2000 |